This is a preview of subscription content, log in via an institution to check access.
References
Younossi ZM, et al. Impact of Interferon Free Regimens on Clinical and Cost Outcomes for Chronic Hepatitis C Genotype 1 Patients. Journal of Hepatology : 19 Nov 2013.
Fairley KJ, et al. Cost-Effectiveness of IL-28 Genotype-Guided Protease Inhibitor Therapy in Hepatitis C-Infected Patients. 78th Annual Scientific Meeting of the American College of Gastroenterology : abstr. P1444, 11 Oct 2013.
Additional information
* 2012 values
Rights and permissions
About this article
Cite this article
IFN-free regimen for hep C genotype 1 cost-effective option. PharmacoEcon Outcomes News 693, 7 (2013). https://doi.org/10.1007/s40274-013-0936-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0936-y